COMMUNIQUÉS West-GlobeNewswire

ADMA Biologics to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
27/08/2018
RAMSEY, N.J. and BOCA RATON, Fla., Aug. 27, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (the “Company”), a vertically integrated commercial biopharmaceutical company that develops, manufactures and [...]
Transactions under Novozymes’ stock buyback program
27/08/2018
Please read the full announcement in the attached PDF Attachment 2018_51_Stock_Buybackprogram_EN
Arcturus Therapeutics to Present at Three Investor Conferences in September
27/08/2018
SAN DIEGO, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company, today announced that Joseph E. Payne will present at the upcoming conferences, including the B. [...]
Emerald Health Therapeutics Signs Term Sheet to Access Large-Scale Extraction, Softgel Production, and New Product Development Capabilities Through Strategic Alliance with Factors Group of Nutritional Companies
27/08/2018
Collaboration with natural health products leader positions Emerald with industry-leading manufacturing for value-added cannabis products, a significant growth opportunity in the legal medical and adult-use cannabis [...]
Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three and Six Months Ended June 30, 2018
27/08/2018
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) announces [...]
Tetraphase Pharmaceuticals to Participate at Upcoming Investor Conferences
27/08/2018
WATERTOWN, Mass., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
Amendment: Biohit Oyj Managers' Transactions
27/08/2018
BIOHIT OYJ AMENDMENT: MANAGERS’ TRANSACTIONS 27 AUGUST 2018 At 13.00 local time (EET) Biohit Oyj: Managers' Transactions Person subject to the notification requirement Name: Ilari Patrakka Position: Other Senior [...]
JAY MOHR to Headline Fullerton Cares ‘Comedy Show for Autism’ - October 19
27/08/2018
FULLERTON, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) -- With new headliner JAY MOHR, the Fullerton Cares ‘Comedy Show for Autism’ in support of Fullerton autism charities and special education programs will be at the [...]
Wright Medical Group N.V. Enters Into Definitive Agreement to Acquire Cartiva, Inc.
27/08/2018
Will Add Unique PMA-Approved Technology for High Volume Foot & Ankle Procedure and Further Accelerate Growth Opportunities in Wright’s Extremities Business Purchase Price of $435 Million Cash Acquisition Expected to [...]
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers
27/08/2018
Sunnyvale, Aug. 27, 2018 (GLOBE NEWSWIRE) -- August 27, 2018 - Sunnyvale, CA – Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces allergy testing partnerships with multiple [...]
Loxo Oncology Announces Submission of European Marketing Authorization Application for Larotrectinib
27/08/2018
STAMFORD, Conn., Aug. 27, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
Photocure ASA: Exclusive Nordic distribution agreement for innovative drug delivery system for bladder cancer patients
27/08/2018
Oslo, Norway, August 27, 2018 : Photocure ASA, The Bladder Cancer Company, announces today that an exclusive distribution agreement for the Nordic area for an innovative and patented medical device has been signed with [...]
FIT Biotech Oy: FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials
27/08/2018
FIT Biotech Oy Press release 27.8.2018 at 08.30 AM EET FIT Biotech has delivered the first batch of FIT-06 vaccine to EHVA clinical trials FIT Biotech Ltd ("FIT Biotech", FITBIO: FN Finland) has delivered the first [...]
Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)
27/08/2018
The EC approval is based on the first global CAR-T registration trials, which included patients from eight European countries and demonstrated durable responses and a consistent safety profile in r/r pediatric B-cell [...]
BeiGene Announces Acceptance of its First New Drug Application for Zanubrutinib in Relapsed/Refractory Mantle Cell Lymphoma by China Drug Administration
27/08/2018
BEIJING, China and CAMBRIDGE, Mass., Aug. 26, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]
Amarin’s REDUCE-IT™ Clinical Study Now Positioned to be Next Large Cardiovascular Outcomes Study to Report Results
26/08/2018
REDUCE-IT is the First Study of Any Therapy to Prospectively Enroll and Evaluate Risk Reduction for Cardiovascular Events in Statin-Treated Patients with Elevated Triglyceride Levels and Other Cardiovascular Risk [...]
Ozempic® consistently reduced the risk of major cardiovascular events across type 2 diabetes populations at high CV risk regardless of prior CV events at baseline
26/08/2018
Munich, Germany, 26 August 2018 - Ozempic ® (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death ( [...]
Downtown Bethesda Welcomes its First Medical Cannabis Dispensary
25/08/2018
MPX Opens Health for Life Dispensary in Bethesda, Maryland Expanding its National Footprint BETHESDA, Md., Aug. 25, 2018 (GLOBE NEWSWIRE) -- MPX Bioceutical Corporation (“ MPX ” or the “ Company ”) (CSE: MPX; OTC: MPXEF [...]
Novartis announces new data that show Entresto® (sacubitril/valsartan) can be initiated early & safely in hospitalized patients after an acute heart failure episode
25/08/2018
TRANSITION shows that Entresto can be safely initiated shortly after an acute heart failure episode, both in the hospital and in an out-patient setting and in a wide range of stabilized patients[1] 83% of chronic heart [...]

Pages